New Surgical Technique Helps Treat Pseudogynecomastia
|
By HospiMedica International staff writers Posted on 02 Jul 2020 |

Image: Illustration of preoperative markings and pertinent reference points (Courtesy of UT Soutwestern)
A novel excisional approach helps male patients with pseudogynecomastia following massive weight loss (MWL), according to a new study.
Developed by researchers at the University of Texas (UT) Southwestern Medical Centre (Dallas, TX, USA) and in private practice, the technique involves a modified elliptical excision and nipple-areola complex (NAC) transposition on a thinned inferior dermal pedicle, in addition to liposuction, as an alternative to conventional mastopexy body contouring procedures for treating male chest deformity after MWL, which often leads to suboptimal results. The researchers reported the results of a retrospective chart review in 14 male patients, who were followed for an average of 8.1 months.
The patients were characterized by age, method of weight loss, pre-weight loss body mass index (BMI), post-weight loss BMI, total weight loss, grade of pseudogynecomastia, and concurrent procedures. The average weight lost was 79.72 kg, with pre-weight loss BMI averaging 52.0 kg/m2 and post-weight loss BMI 29.6 kg/m2. The average amount of tissue removed was 2,615 grams. In all, 28.6% of the patients experienced minor complications, including asymmetry, delayed wound healing, hyperpigmentation, and seroma. There were no wound infections, hematomas, flap necrosis, or dysesthesia. The study was published on June 16, 2020, in Aesthetic Surgery Journal: Open Forum.
“Due to several cosmetic advantages and low complication profile, our technique is an attractive option for treating male chest deformity after MWL,” concluded senior author Professor Jeffrey Kenkel, MD, of UT Southwestern Medical Center, and colleagues. “This is a nice alternative to the standard nipple grafting techniques we have used for years. It allows us to preserve the shape of the nipple and in many cases the color in patients of color.”
Pseudogynecomastia is defined by retained retroareolar fat without glandular hypertrophy, often with excess tissue and skin anteriorly and laterally; this in contrast to gynecomastia, which is often idiopathic and results in proliferation of glandular tissue. Treatment for pseudogynecomastia generally requires excision of excess tissue and skin for all but the mildest forms.
Related Links:
University of Texas Southwestern Medical Centre
Developed by researchers at the University of Texas (UT) Southwestern Medical Centre (Dallas, TX, USA) and in private practice, the technique involves a modified elliptical excision and nipple-areola complex (NAC) transposition on a thinned inferior dermal pedicle, in addition to liposuction, as an alternative to conventional mastopexy body contouring procedures for treating male chest deformity after MWL, which often leads to suboptimal results. The researchers reported the results of a retrospective chart review in 14 male patients, who were followed for an average of 8.1 months.
The patients were characterized by age, method of weight loss, pre-weight loss body mass index (BMI), post-weight loss BMI, total weight loss, grade of pseudogynecomastia, and concurrent procedures. The average weight lost was 79.72 kg, with pre-weight loss BMI averaging 52.0 kg/m2 and post-weight loss BMI 29.6 kg/m2. The average amount of tissue removed was 2,615 grams. In all, 28.6% of the patients experienced minor complications, including asymmetry, delayed wound healing, hyperpigmentation, and seroma. There were no wound infections, hematomas, flap necrosis, or dysesthesia. The study was published on June 16, 2020, in Aesthetic Surgery Journal: Open Forum.
“Due to several cosmetic advantages and low complication profile, our technique is an attractive option for treating male chest deformity after MWL,” concluded senior author Professor Jeffrey Kenkel, MD, of UT Southwestern Medical Center, and colleagues. “This is a nice alternative to the standard nipple grafting techniques we have used for years. It allows us to preserve the shape of the nipple and in many cases the color in patients of color.”
Pseudogynecomastia is defined by retained retroareolar fat without glandular hypertrophy, often with excess tissue and skin anteriorly and laterally; this in contrast to gynecomastia, which is often idiopathic and results in proliferation of glandular tissue. Treatment for pseudogynecomastia generally requires excision of excess tissue and skin for all but the mildest forms.
Related Links:
University of Texas Southwestern Medical Centre
Latest Surgical Techniques News
- Fiber-Form Bone Graft Expands Intraoperative Options for Spinal Fusion
- Ultrasound‑Aided Catheter Treatment Cuts Early Collapse in Pulmonary Embolism
- Ultrasound Technology Aims to Replace Invasive BPH Procedures
- Continuous Monitoring with Wearables Enhances Postoperative Patient Safety
- New Approach Enables Customized Muscle Tissue Without Biomaterial Scaffolds
- Robot-Assisted Brain Angiography Improves Procedural Outcomes
- Brain Mapping Technology Enhances Precision in Brain Tumor Resection
- Handheld Robotic System Expands Options for Total Knee Surgery
- VR Experience Reduces Patient Anxiety Before Kidney Stone Procedure
- Injectable Mini Livers Offer Hope for Patients Awaiting Transplant
- Pulsed Field Ablation Technology Cleared in Europe for Persistent AFib
- AI-Powered Imaging Brings Real-Time Margin Clarity to Breast Cancer Surgery
- Minimally Invasive Device Safely Treats Challenging Brain Aneurysms
- Surgical Robot Makes Complex Liver Tumor Surgery Safer and Less Invasive
- Neurostimulation Implant Reduces Seizure Burden in Drug-Resistant Epilepsy
- Minimally Invasive Procedure Effectively Treats Small Kidney Cancers
Channels
Artificial Intelligence
view channelAI Analysis of Pericardial Fat Refines Long-Term Heart Disease Risk
Accurately identifying long-term cardiovascular disease risk in asymptomatic adults remains challenging for clinicians. Missed or underestimated risk delays preventive therapy and increases the chance... Read more
Machine Learning Approach Enhances Liver Cancer Risk Stratification
Hepatocellular carcinoma, the most common form of primary liver cancer, is often detected late despite targeted surveillance programs. Current screening guidelines emphasize patients with known cirrhosis,... Read moreCritical Care
view channel
Angiography-Based FFR Approach Matches Gold Standard Results Without Wires
Accurately determining whether a coronary stenosis limits blood flow is essential to guide percutaneous coronary intervention, yet wire-based physiologic testing remains underused due to added procedural... Read more
Eye Imaging AI Identifies Elevated Cardiovascular Risk
Many adults at risk for atherosclerotic cardiovascular disease are not identified until they undergo formal primary care assessment. Delayed risk recognition can postpone initiation of statins and lifestyle... Read morePatient Care
view channel
Wearable Sleep Data Predict Adherence to Pulmonary Rehabilitation
Chronic obstructive pulmonary disease (COPD) is a long-term lung disorder that makes breathing difficult and often disturbs sleep, reducing energy for daily activities. Limited engagement in pulmonary... Read more
Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care
More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read moreHealth IT
view channel
Voice-Driven AI System Enables Structured GI Procedure Documentation
Documentation during gastrointestinal (GI) procedures often competes with real-time clinical decision-making and imposes a significant cognitive burden on physicians. Manual data entry and post-procedure... Read more
EMR-Based Tool Predicts Graft Failure After Kidney Transplant
Kidney transplantation offers patients with end-stage kidney disease longer survival and better quality of life than dialysis, yet graft failure remains a major challenge. Although a successful transplant... Read more
Printable Molecule-Selective Nanoparticles Enable Mass Production of Wearable Biosensors
The future of medicine is likely to focus on the personalization of healthcare—understanding exactly what an individual requires and delivering the appropriate combination of nutrients, metabolites, and... Read moreBusiness
view channel







